Highlights Circio Holding ASA

Equities

TRVX

NO0013033795

Real-time Oslo Bors Other stock markets 06:38:52 2024-05-21 am EDT			5-day change	1st Jan Change
2.16 ^NOK	-4.00%		+6.93%	-70.00%

Apr. 25	Circio Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 17	Circio Establishes In Vivo Proof-of-Concept for Circular RNA Platform	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Circio Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Circio Establishes In Vivo Proof-of-Concept for Circular RNA Platform	Apr. 17	MT
Circio Terminates Cancer Vaccine License Deal in China	Apr. 17	MT
Circio Announces in Vivo Proof-Of-Concept for Its circVec circular RNA Platform Technology and Reinforced Gene Therapy Focus	Apr. 17	CI
Circio Holding ASA Terminates TG01 Cancer Vaccine License Option Agreement with IOVaxis therapeutics in China for Non-Payment	Apr. 17	CI
Circio Partner Exercises Option to License Cancer Vaccine in China	Mar. 19	MT
Circio Holding ASA Announces Partner IOVaxis Therapeutics Exercises the Option for an Exclusive License to Mutant RAS Cancer Vaccine TG01 in China	Mar. 19	CI
Circio Holding ASA Announces Dosing of First Patient in the Collaborative Phase 2 Trial Sponsored by Georgetown University	Feb. 01	CI
Atlas Special Opportunities Converts NOK1 Million of Circio Convertible Bonds	Jan. 10	MT
Circio Partner Files Investigational New Drug Application for Cancer Vaccine in China	Dec. 12	MT
IOVaxis Therapeutics Files Updated TG01 Investigational New Drug Application with the Chinese National Medical Products Administration	Dec. 12	CI
Circio Holding ASA Announces Completion of Planned Safety Review and Opening for Full Enrollment of TG01 Study At Oslo University Hospital	Dec. 07	CI
Circio Joins Collaboration to Test the Combination of TG01 Vaccination with Daratumumab and Nivolumab in Immunotherapy-Resistant Patients with Mutant RAS Cancers	Nov. 16	CI
Circio, Neoregen Biotech Enter Research Partnership on Circular RNA Therapeutics	23-10-10	MT
Circio Holding ASA and Neoregen Biotech Enter Collaboration for Delivery of Novel Circular Rna Therapeutics Using Nict Technology	23-10-10	CI
Circio Holding Asa Announces Oncos-102 Mesothelioma Study Published in Journal for Immunotherapy of Cancer	23-09-03	CI
Circio Holding ASA Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Targovax ASA Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-15	CI
Targovax ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-15	CI
Targovax Obtains Regulatory Clearance For Clinical Trial Of Multiple Myeloma Vaccine	22-12-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Circio Holding ASA

Equities

TRVX

NO0013033795

Highlights

Filters